Prediction Case File
YouTubeTracking Live

BE Bloom Energy Q3 2026 Earnings Oct 22: 5 Stock Signals + Tuesday Predicted Opening Price? πŸ”₯

1 extracted signal Β· 0 resolved Β· 1 still active

StockInvest.us profile imageStockInvest.usIndependent analyst profile
Source published
20 Oct 2026, 00:11 UTC
Recorded by Tahlil Plus
20 Oct 2026, 02:11 UTC
Video preview for BE Bloom Energy Q3 2026 Earnings Oct 22: 5 Stock Signals + Tuesday Predicted Opening Price? πŸ”₯
Source overview

AI-generated source summary

The stock is currently in an upward trend, evidenced by the 50-day moving average (MA) of $167.08 and the 200-day MA of $152.96. The stock price is above both MAs, indicating bullishness. The volume at the last close was 99.01 million, with an average volume of 58.18 million. This higher-than-average volume signifies increased investor interest. Apple's earnings per share (EPS) stand at $5.89, with a price-to-earnings (PE) ratio of 30.09, indicating consistent growth and a relatively flat valuation. The company has 15.73 billion shares outstanding, which is a significant number for its market cap. The company's upcoming earnings announcement is expected on July 26. The stock currently resides in the lower part of a broad and robust upward trend in the short term, which typically presents a favorable buying opportunity. If the trend floor at $222.20 is breached, it would initially suggest a deceleration in the rate of increase and might also serve as an early warning for a potential trend reversal. The existing three-month trend indicates a potential 37.32% change over the upcoming three months, with a potential return ranging from 35.13% to 86.67%. In current terms, this suggests the future price could range between $303.40 and $424.12 over the next year. The stock's recent performance shows it gained 2.22% on Monday, October 20th, closing at $226.22. However, there is a significant gap between the current price and the 52-week high of $351.28. The stock also experienced a -35.60% fall in the last 52 weeks. The stock is currently trading at $226.22, with key Fibonacci support and resistance levels at $224.42 and $228.11, respectively. The calculated support level is $218.32, while the next resistance is at $237.27. The stock exhibits high volatility with a weekly volatility of 7.65%. The risk level is High. The stock's price-to-earnings ratio is 242.26, suggesting it might be overvalued, although this is not unusual for tech companies with significant market potential. Insider trading data indicates a net sell, with an insider power of -23.276. Analyst ratings are mixed, with a neutral rating from Roth Capital, a buy from UBS, and a market perform from Bernstein. The stock is currently designated as a Sell Candidate, with a projected price of $227.97 for Tuesday, October 20th.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
β€”
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

StockInvest.us

Platform-wide history, separate from this source evaluation.

Reliability
53.4
Tracked signals
1799
Historical success
42.8%
View full analyst profile β†’
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail